Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin vitamin C-based nanovesicles improved hair growth and reduced hair loss in androgenic alopecia patients.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

Platelet-rich plasma injections can effectively treat male pattern hair loss, improving hair density and quality with high patient satisfaction.

Dutasteride successfully treated a woman's hair loss when other treatments failed.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

There is no significant link between male pattern baldness and insulin resistance.

Platelet-Rich Plasma (PRP) treatment may increase hair growth for genetic hair loss, but more research is needed to confirm this.

Chronic exposure to sunlight may worsen male pattern baldness and protecting the scalp from the sun could slow it down.

The laser scanner device was more effective at increasing hair density than the laser hat in treating androgenic alopecia.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Multimodal minoxidil microemulsion is more effective in treating hair loss than minoxidil alone.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Low-level laser therapy significantly increases hair density in adults with hair loss, with low-frequency treatment being more effective.

Finasteride may cause mental and sexual side effects, with hand preference and sexual orientation possibly affecting severity.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

PRP shows promise for treating hair loss but needs more research.